
The episode discusses the process of technology transfer at UCLA and its impact on turning scientific discoveries into viable therapies.
A single university discovery can turn into a life-changing therapy, but only if someone can translate the science into a product, a company, and a development plan investors will actually fund. That is why we sat down with Mark from UCLA’s technology transfer and licensing team to demystify what happens after the lab result and before the biotech headline. We talk plainly about what a tech transfer office does, what it can license, and why “intellectual property” now stretches beyond patents...
Explore listener stats, chart rankings, contacts and more on the The Lattice (Official 3DHEALS Podcast) podcast page.